Patent · US Active

Nucleic acids encoding human immunodeficiency virus type 1 (HIV-1) N-terminal deleted gp120 immunogens and methods of use

US11053285B2 · kind B2 · utility

0Cited by

10References

25Claims

0Family size

Assignees

Duke University · US
The Government of the United States, as represented by the Secretary of the Army · US
Children's Medical Center Corporation · US

Inventors

Jerome Kim · Fort Detrick, US
Stephen C. Harrison · Cambridge, US
Barton F. Haynes · Durham, US
Georgia Tomaras · Durham, US
Nelson Michael · Fort Detrick, US

Key dates

Filing date	Jun 27, 2018
Grant date	Jul 6, 2021
Priority date	—
Expiry date	Jun 27, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/16134
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.